These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3025934)
1. Workshop: Potential therapeutic uses of inhibitors of leukotriene generation and function. June 23, 1986, Bethesda, Maryland. Sponsored by the National Institute of Allergy and Infectious Diseases and the World Health Organization Collaborating Center for Allergic Diseases. Massicot JG; Soberman RJ; Ackerman NR; Heavey D; Roberts LJ; Austen KF Prostaglandins; 1986 Oct; 32(4):481-94. PubMed ID: 3025934 [No Abstract] [Full Text] [Related]
2. Pharmacology and physiology of leukotrienes and their antagonists. Barnes N; Evans J; Zakrzewski J; Piper P; Costello J Ann N Y Acad Sci; 1988; 524():369-78. PubMed ID: 2837971 [No Abstract] [Full Text] [Related]
4. 5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig. Garceau D; Ford-Hutchinson AW; Charleson S Eur J Pharmacol; 1987 Nov; 143(1):1-7. PubMed ID: 2826183 [TBL] [Abstract][Full Text] [Related]
5. Prospects for the inhibition of leukotriene synthesis. Bach MK Biochem Pharmacol; 1984 Feb; 33(4):515-21. PubMed ID: 6322805 [No Abstract] [Full Text] [Related]
6. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist. Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426 [TBL] [Abstract][Full Text] [Related]
7. The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Rokach J; Young RN Adv Exp Med Biol; 1989; 259():75-108. PubMed ID: 2560345 [No Abstract] [Full Text] [Related]
11. [Biological role of lipoxygenases]. Robak J; Duniec Z Postepy Hig Med Dosw; 1983; 37(2):177-93. PubMed ID: 6320146 [No Abstract] [Full Text] [Related]
12. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206 [TBL] [Abstract][Full Text] [Related]
13. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. Touvay C; Vilain B; Sirois P; Soufir M; Braquet P J Pharm Pharmacol; 1987 Jun; 39(6):454-8. PubMed ID: 2886603 [TBL] [Abstract][Full Text] [Related]
18. [Leukotrienes and other products of lipoxygenases. Nature and biological profile]. Gimeno AL Acta Physiol Pharmacol Latinoam; 1985; 35(1):67-92. PubMed ID: 2998154 [No Abstract] [Full Text] [Related]
19. Effect of BI-L-239, A-64077 and MK-886 on leukotriene B4 synthesis by chopped guinea pig lung and on antigen-induced tracheal contraction in vitro. Noonan TC; Jamieson-Leclercq T; Desai SN Prostaglandins; 1992 Dec; 44(6):543-54. PubMed ID: 1335586 [TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Prosiegel M; Neu I; Mallinger J; Wildfeuer A; Mehlber L; Vogl S; Hoffmann G; Ruhenstroth-Bauer G Acta Neurol Scand; 1989 Mar; 79(3):223-6. PubMed ID: 2541593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]